BFM
NVS icon

Boothbay Fund Management’s Novartis NVS Stock Holding History

Boothbay Fund Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-75,700
Closed -$7.64M – 1970
2023
Q2 		$7.64M Buy
+75,700
New +$7.57M 0.17% 118

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Boothbay Fund Management's NVS Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Novartis (NVS) in Q2 2026: 14,644 shares worth $2.3M. The stake represents 0.03% of the portfolio and ranks #665 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in NVS as recently as Q2 2024.

Boothbay Fund Management first reported a position in NVS in Q3 2019 and has held it in 13 quarters since. The position peaked at $26.7M in Q1 2024. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Boothbay Fund Management held 14,644 shares of Novartis worth $2.3M as of Q2 2026.
  • Novartis was a new Boothbay Fund Management position in Q2 2026.
  • Novartis made up 0.03% of Boothbay Fund Management's portfolio in Q2 2026, its #665 holding.
  • Boothbay Fund Management first reported a position in Novartis in Q3 2019 and has held it in 13 quarters since.
  • Boothbay Fund Management's Novartis position peaked at $26.7M in Q1 2024.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.